Business Context and Reporting Period
Company: Harvard Bioscience, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: April 30, 2009
Reporting Period: Three months ended March 31, 2009
This filing serves to announce the issuance of a press release regarding the Company's financial results for the quarter ended March 31, 2009. The press release is included as Exhibit 99.1 and incorporated by reference.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained within the referenced press release (Exhibit 99.1) but are not explicitly stated in the body of this Form 8-K.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. It only confirms that results for the three months ended March 31, 2009, were announced.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release issued on April 30, 2009, but does not summarize the content of that commentary.
Legal Disclaimer: The information in Item 2.02 and Exhibit 99.1 is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section, nor is it incorporated by reference in other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for the quarter ended March 31, 2009.
- Verify year-over-year comparisons and management's outlook details within the attached press release.
- Confirm the legal status of the financial data, noting the disclaimer that it is not "filed" for liability purposes under Section 18 of the Exchange Act.